ConductScience.org, home

Paper32166202

Complications following Encephalo-Duro-Arterio-Myo-Synangiosis in a case of Moyamoya disease.

Hazra DN and 1 other. Brain Circ, 2020. Cited by 4 papers, by iCite.

Cite this record

ConductScience Library. Complications following Encephalo-Duro-Arterio-Myo-Synangiosis in a case of Moyamoya disease. Papers, record 32166202. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32166202

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Complications following Encephalo-Duro-Arterio-Myo-Synangiosis in a case of Moyamoya disease.
PubMed
Journal
Brain Circ
PubMed
Year
2020
PubMed
Publication types
Case Reports, Journal Article
PubMed
Citations, by iCite
4
iCite
Relative citation ratio, by iCite
0.25
iCite
Revised in PubMed
2020-09-28
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hazra DNDarpa Narayan
2Ghosh AKAmit Kumar

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References10

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
118352765Surgical treatment of moyamoya syndrome in patients with sickle cell anemia: outcome following encephaloduroarteriosynangiosis.J Neurosurg Pediatr2008https://conductscience.org/library/papers/18352765PubMed
2712390Treatment of moyamoya disease with STA-MCA anastomosis.J Neurosurg1978https://conductscience.org/library/papers/712390PubMed
39183345Effects of surgical revascularization on outcome of patients with pediatric moyamoya disease.Stroke1997https://conductscience.org/library/papers/9183345PubMed
48711799Surgical therapy for adult moyamoya disease. Can surgical revascularization prevent the recurrence of intracerebral hemorrhage?Stroke1996https://conductscience.org/library/papers/8711799PubMed
59356100Risk factors for neurologic deterioration after revascularization surgery in patients with moyamoya disease.Anesth Analg1997https://conductscience.org/library/papers/9356100PubMed
63351581Pitfalls in the surgical treatment of moyamoya disease. Operative techniques for refractory cases.J Neurosurg1988https://conductscience.org/library/papers/3351581PubMed
726846757Moyamoya Disease: Treatment and Outcomes.J Stroke2016https://conductscience.org/library/papers/26846757PubMed
823746127Postoperative epidural hematoma covering the galeal flap in pediatric patients with moyamoya disease: clinical manifestation, risk factors, and outcomes.J Neurosurg Pediatr2013https://conductscience.org/library/papers/23746127PubMed
98474642Surgical treatment of moyamoya disease: operative technique for encephalo-duro-arterio-myo-synangiosis, its follow-up, clinical results, and angiograms.Neurosurgery1993https://conductscience.org/library/papers/8474642PubMed
1019463046Clinical outcome after 450 revascularization procedures for moyamoya disease. Clinical article.J Neurosurg2009https://conductscience.org/library/papers/19463046PubMed

Download CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.

PMIDTitleJournalYearIn PapersSource
41798800Preliminary comparison of efficacy and safety between direct bypass surgery and endovascular recanalization therapy in adult ischemic moyamoya disease.Front Neurol2026https://conductscience.org/library/papers/41798800PubMed
37927203Remote ischemic conditioning after stroke: Research progress in clinical study.CNS Neurosci Ther2024https://conductscience.org/library/papers/37927203PubMed
36761030Superficial temporal artery-middle cerebral artery bypass in combination with encephalo-myo-synangiosis in Chinese adult patients with moyamoya disease.Front Surg2023https://conductscience.org/library/papers/36761030PubMed
35185755Daily Remote Ischemic Conditioning Can Improve Cerebral Perfusion and Slow Arterial Progression of Adult Moyamoya Disease-A Randomized Controlled Study.Front Neurol2021https://conductscience.org/library/papers/35185755PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
PRTN35657PubTator's text mininghttps://conductscience.org/library/genes/5657

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/32166202

GET https://conductscience.org/api/papers/v1/32166202/authors